In its latest quarterly filing, Merit Medical Systems demonstrated robust growth driven by its cardiovascular and endoscopy segments, reflecting strong customer demand for its broad range of minimally invasive proprietary devices and custom procedural solutions. The company’s direct sales force and distributor networks continue to deepen market penetration, bolstered by its innovation pipeline aligned with regulatory approvals. However, restrictive debt covenants related to $747.5 million in convertible notes and geopolitical tensions pose tangible risks to financial flexibility. Monitoring sales momentum, execution of product launches, and covenant compliance will be critical in the near term.